| BAP1 and YY1 regulate expression of death receptors in malignant pleural mesothelioma. |
Ishii Y, Kolluri KK, Pennycuick A, Zhang X, Nigro E, Alrifai D, Borg E, Falzon M, Shah K, Kumar N, Janes SM. |
2021 |
J Biol Chem |
Link
|
| MesobanK UK: an international mesothelioma bioresource. |
Rintoul RC, Rassl DM, Gittins J, Marciniak SJ, MesobanK collaborators. |
2016 |
Thorax |
Link
|
| Use of preclinical models for malignant pleural mesothelioma. |
Shamseddin M, Obacz J, Garnett MJ, Rintoul RC, Francies HE, Marciniak SJ. |
2021 |
Thorax |
Link
|
| Exploring High Aspect Ratio Gold Nanotubes as Cytosolic Agents: Structural Engineering and Uptake into Mesothelioma Cells. |
Ye S, Azad AA, Chambers JE, Beckett AJ, Roach L, Moorcroft SCT, Aslam Z, Prior IA, Markham AF, Coletta PL, Marciniak SJ, Evans SD. |
2020 |
Small |
Link
|
| Biological basis for novel mesothelioma therapies. |
Obacz J, Yung H, Shamseddin M, Linnane E, Liu X, Azad AA, Rassl DM, Fairen-Jimenez D, Rintoul RC, Nikolić MZ, Marciniak SJ. |
2021 |
Br J Cancer |
Link
|
| Surface-fill hydrogel attenuates the oncogenic signature of complex anatomical surface cancer in a single application. |
Majumder P, Singh A, Wang Z, Dutta K, Pahwa R, Liang C, Andrews C, Patel NL, Shi J, de Val N, Walsh STR, Jeon AB, Karim B, Hoang CD, Schneider JP. |
2021 |
Nat Nanotechnol |
Link
|
| MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis. |
Singh A, Pruett N, Pahwa R, Mahajan AP, Schrump DS, Hoang CD. |
2021 |
Mol Ther Nucleic Acids |
Link
|
| Integrated genomics point to immune vulnerabilities in pleural mesothelioma. |
Nastase A, Mandal A, Lu SK, Anbunathan H, Morris-Rosendahl D, Zhang YZ, Sun XM, Gennatas S, Rintoul RC, Edwards M, Bowman A, Chernova T, Benepal T, Lim E, Taylor AN, Nicholson AG, Popat S, Willis AE, MacFarlane M, Lathrop M, Bowcock AM, Moffatt MF, Cookson WOCM. |
2021 |
Sci Rep |
Link
|
| Normal mesothelial cell lines newly derived from human pleural biopsy explants. |
Pruett N, Singh A, Shankar A, Schrump DS, Hoang CD. |
2020 |
Am J Physiol Lung Cell Mol Physiol |
Link
|
| Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells. |
Kolluri KK, Alifrangis C, Kumar N, Ishii Y, Price S, Michaut M, Williams S, Barthorpe S, Lightfoot H, Busacca S, Sharkey A, Yuan Z, Sage EK, Vallath S, Le Quesne J, Tice DA, Alrifai D, von Karstedt S, Montinaro A, Guppy N, Waller DA, Nakas A, Good R, Holmes A, Walczak H, Fennell DA, Garnett M, Iorio F, Wessels L, McDermott U, Janes SM. |
2018 |
Elife |
Link
|
| Integrative Molecular Characterization of Malignant Pleural Mesothelioma. |
Hmeljak J, Sanchez-Vega F, Hoadley KA, Shih J, Stewart C, Heiman D, Tarpey P, Danilova L, Drill E, Gibb EA, Bowlby R, Kanchi R, Osmanbeyoglu HU, Sekido Y, Takeshita J, Newton Y, Graim K, Gupta M, Gay CM, Diao L, Gibbs DL, Thorsson V, Iype L, Kantheti H, Severson DT, Ravegnini G, Desmeules P, Jungbluth AA, Travis WD, Dacic S, Chirieac LR, Galateau-Sallé F, Fujimoto J, Husain AN, Silveira HC, Rusch VW, Rintoul RC, Pass H, Kindler H, Zauderer MG, Kwiatkowski DJ, Bueno R, Tsao AS, Creaney J, Lichtenberg T, Leraas K, Bowen J, TCGA Research Network, Felau I, Zenklusen JC, Akbani R, Cherniack AD, Byers LA, Noble MS, Fletcher JA, Robertson AG, Shen R, Aburatani H, Robinson BW, Campbell P, Ladanyi M. |
2018 |
Cancer Discov |
Link
|
| The Chick Embryo Xenograft Model for Malignant Pleural Mesothelioma: A Cost and Time Efficient 3Rs Model for Drug Target Evaluation. |
Barnett SE, Herrmann A, Shaw L, Gash EN, Poptani H, Sacco JJ, Coulson JM. |
2022 |
Cancers (Basel) |
Link
|
| MesoGraph: Automatic profiling of mesothelioma subtypes from histological images. |
Eastwood M, Sailem H, Marc ST, Gao X, Offman J, Karteris E, Fernandez AM, Jonigk D, Cookson W, Moffatt M, Popat S, Minhas F, Robertus JL. |
2023 |
Cell Rep Med |
Link
|